Universal vaccine against respiratory syncytial virus A and B subtypes.
about
Respiratory Syncytial Virus (RSV): Targeting the G Protein Provides a New Approach for an Old Problem.Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine.Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection.Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles.Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.
P2860
Universal vaccine against respiratory syncytial virus A and B subtypes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Universal vaccine against respiratory syncytial virus A and B subtypes.
@ast
Universal vaccine against respiratory syncytial virus A and B subtypes.
@en
type
label
Universal vaccine against respiratory syncytial virus A and B subtypes.
@ast
Universal vaccine against respiratory syncytial virus A and B subtypes.
@en
prefLabel
Universal vaccine against respiratory syncytial virus A and B subtypes.
@ast
Universal vaccine against respiratory syncytial virus A and B subtypes.
@en
P2860
P1433
P1476
Universal vaccine against respiratory syncytial virus A and B subtypes.
@en
P2093
Jeong-Yoon Lee
P2860
P304
P356
10.1371/JOURNAL.PONE.0175384
P407
P50
P577
2017-04-06T00:00:00Z